Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection.
about
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals.Human Immunodeficiency Virus Localization in Human Papillomavirus-Related, High-Grade Squamous Intraepithelial Lesions of the Cervix in Women with HIV Infection: Microdissection and Molecular Analysis on Formalin-Fixed and Paraffin-Embedded SpecimenRole of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia.Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection.Novel family of gynecologic cancer antigens detected by anti-HIV antibody.Correlates to Human Papillomavirus Vaccination Status and Willingness to Vaccinate in Low-Income Philadelphia High School Students.Therapeutic evaluation of intralesional 5% 5-fluorouracil in condyloma acuminata.Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.Topical treatment for human papillomavirus-associated genital warts in humans with the novel tellurium immunomodulator AS101: assessment of its safety and efficacy.
P2860
Q33692334-B42DA1CC-90B3-4BF1-AE99-052B94421802Q35562273-EEE77BAA-A493-4122-9962-3358025B3536Q35624093-98B1C1B2-36B0-4429-92A5-E3FEB1971175Q35833443-F1C0A0ED-3621-466E-8291-5CC837C2BD26Q36543293-C8A7D720-2F9E-4D9B-BF18-FD3390B700E4Q36624683-C66B4A41-9BCC-46E9-9079-DBF3E283A476Q40294202-D824EA96-35D5-4810-8F5F-5854E42303BBQ44929190-E9E48585-EF36-4D0D-95CB-AC2EE92F5795Q45384251-93BCCA98-5ADC-49E1-A946-94F7B6A2B962Q46353434-2A4C968D-F941-4470-A9AF-2267E6201ADD
P2860
Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Human immunodeficiency virus-i ...... uman papillomavirus infection.
@en
Human immunodeficiency virus-i ...... uman papillomavirus infection.
@nl
type
label
Human immunodeficiency virus-i ...... uman papillomavirus infection.
@en
Human immunodeficiency virus-i ...... uman papillomavirus infection.
@nl
prefLabel
Human immunodeficiency virus-i ...... uman papillomavirus infection.
@en
Human immunodeficiency virus-i ...... uman papillomavirus infection.
@nl
P2093
P1476
Human immunodeficiency virus-i ...... uman papillomavirus infection.
@en
P2093
A Rementeria
F J Rodriguez-Escudero
G Gutierrez de Terán
J M Ariceta
R Matorras
P356
10.1016/0002-9378(91)90620-7
P407
P433
P577
1991-01-01T00:00:00Z